TRI-MIX 30/1/20 Injectable Recalled for Lack of Sterility Assurance
Carolina Infusion is recalling TRI-MIX 30/1/20 Injectable vials due to lack of assurance of sterility. The recall affects multiple lots distributed nationwide.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall with lack of sterility assurance on an injectable product. This is a risk-of-harm product where injury has not yet been reported. No illnesses or adverse events have been reported, placing this in the High category per the rubric.
Plain-English summary
Carolina Infusion LLC is recalling TRI-MIX 30/1/20 Injectable (5 mL vials), a prescription medication distributed nationwide in the United States.
The recall was issued due to lack of assurance of sterility. Injectable medications must meet strict sterility standards to prevent microbial contamination. The manufacturer cannot verify that this product meets these required standards.
The recall affects seven vials across multiple lots with beyond-use dates ranging from August 2022 to October 2022. Affected lots are: 06272022@6 (BUD 08/26/2022), 07212022@3 (BUD 09/19/2022), 07292022@11 (BUD 09/27/2022), 08052022@7 (BUD 10/04/2022), 08102022@5 (BUD 10/09/2022), 08122022@14 (BUD 10/11/2022), and 08172022@7 (BUD 10/16/2022).
Healthcare providers and patients who may have this product should contact their healthcare provider. No illnesses or adverse events have been reported in connection with this recall to date.
The recalled product
- Product
- TRI-MIX 30/1/20 Injectable, 5 ML vial, Rx only, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936.
- Manufacturer
- Carolina Infusion
- Category
- Drug — Compounded Injectable
- Affected units
- 7
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (7)
- Lots: 06272022@6 BUD: 08/26/2022
- 07212022@3 BUD: 09/19/2022
- 07292022@11 BUD: 09/27/2022
- 08052022@7 BUD: 10/04/2022
- 08102022@5 BUD: 10/09/2022
- 08122022@14 BUD: 10/11/2022
- 08172022@7 BUD: 10/16/2022
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 20 recalled by Carolina Infusion under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 20 products in this recall →Related recalls
Same manufacturer · Carolina Infusion
See all →- HighInjectable drug product recalled for lack of sterility assurance
FDA (Drugs) · 2022-09-21
- HighInjectable Steroid Product Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2022-09-21
- HighInjectable testosterone product recalled for sterility assurance defect
FDA (Drugs) · 2022-09-21
- HighInjectable Medication TRI-MIX Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2022-09-21
- HighSermorelin Acetate Injectable Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2022-09-21
Same hazard · lack of sterility
See all →- HighRohto Cooling Eye Drops Max Strength Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- HighRohto Cooling Eye Drops Recalled Due to Lack of Assurance of Sterility
FDA (Drugs) · 2026-07-29
- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- SeverePemetrexed for Injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-07-15
- SevereAzacitidine for Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2026-07-15